Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

HDL: a recipe for longevity.

Philip Barter1

  • 1The Heart Research Institute, 145 Missenden Road, Camperdown, Sydney, NSW 2050, Australia. p.barter@hri.org.au

Atherosclerosis. Supplements
|May 4, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Prevalence of plasma lipid disorders with an emphasis on LDL cholesterol in selected countries in the Asia-Pacific region.

Lipids in health and disease·2021
Same author

Waist circumference as a vital sign in clinical practice: a Consensus Statement from the IAS and ICCR Working Group on Visceral Obesity.

Nature reviews. Endocrinology·2020
Same author

Visceral and ectopic fat, atherosclerosis, and cardiometabolic disease: a position statement.

The lancet. Diabetes & endocrinology·2019
Same author

HDL cholesterol and ASCVD risk stratification: A debate.

Atherosclerosis·2019
Same author

Expert opinion on the applicability of dyslipidemia guidelines in Asia and the Middle East.

International journal of general medicine·2018
Same author

Triglyceride-Rich Lipoprotein Cholesterol and Risk of Cardiovascular Events Among Patients Receiving Statin Therapy in the TNT Trial.

Circulation·2018
Same journal

'Diet and lifestyle' in the management of dyslipidaemia and prevention of CVD - Understanding the level of knowledge and interest of European Atherosclerosis Society members.

Atherosclerosis. Supplements·2021
Same journal

Improving lipid management in patients with acute coronary syndrome: The ACS Lipid EuroPath tool.

Atherosclerosis. Supplements·2021
Same journal

Lipid Clinics Network. Rationale and design of the EAS global project.

Atherosclerosis. Supplements·2021
Same journal

Implementation of clinical practices and pathways optimizing ACS patients lipid management: Focus on eight European initiatives.

Atherosclerosis. Supplements·2021
Same journal

Lipid-lowering therapy and low-density lipoprotein cholesterol goal achievement in patients with acute coronary syndromes: The ACS patient pathway project.

Atherosclerosis. Supplements·2021
Same journal

Prevalence and relationship between metabolic syndrome and risk of cardiovascular disease: Evidence from two population-based studies.

Atherosclerosis. Supplements·2021
See all related articles

High-density lipoprotein cholesterol (HDL-C) protects against heart disease and stroke. Research supports interventions aimed at increasing HDL-C levels for cardiovascular health.

Area of Science:

  • Cardiovascular Science
  • Lipid Metabolism
  • Preventive Cardiology

Background:

  • High-density lipoprotein cholesterol (HDL-C) is a key negative predictor of premature coronary heart disease (CHD) and stroke.
  • Protective functions of HDLs are evident in various populations, including the elderly and their offspring.
  • HDLs possess anti-atherogenic properties through multiple mechanisms.

Purpose of the Study:

  • To review the evidence supporting HDL-C's protective role in cardiovascular health.
  • To explore the potential of interventions that increase HDL-C concentrations.
  • To highlight the shift in focus from LDL-C reduction to HDL-C elevation in CHD prevention strategies.

Main Methods:

  • Review of human prospective population studies.

Related Experiment Videos

  • Analysis of evidence on HDL functions and anti-atherogenic mechanisms.
  • Examination of lifestyle and pharmacological interventions affecting HDL-C levels.

    • Main Results:

    • Consistent data demonstrate HDL-C as a significant negative predictor of CHD and stroke.
    • HDLs exhibit protective functions relevant to preventing atherosclerosis.
    • Existing interventions can effectively raise HDL-C levels.

    Conclusions:

    • Growing evidence supports the atheroprotective role of HDL-C.
    • Interventions targeting an increase in HDL-C concentrations are gaining traction in CHD prevention.
    • Future strategies may increasingly focus on raising HDL-C levels for cardiovascular benefit.